113 related articles for article (PubMed ID: 8762329)
21. The influence of human papillomavirus on nasopharyngeal carcinoma in Japan.
Kano M; Kondo S; Wakisaka N; Moriyama-Kita M; Nakanishi Y; Endo K; Murono S; Nakamura H; Yoshizaki T
Auris Nasus Larynx; 2017 Jun; 44(3):327-332. PubMed ID: 27499435
[TBL] [Abstract][Full Text] [Related]
22. In vivo real-time diagnosis of nasopharyngeal carcinoma in situ by contact rhinoscopy.
Wai Pak M; To KF; Lee JC; Liang EY; van Hasselt CA
Head Neck; 2005 Nov; 27(11):1008-13. PubMed ID: 16134185
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
Jiang C; Chen J; Xie S; Zhang L; Xiang Y; Lung M; Kam NW; Kwong DL; Cao S; Guan XY
Int J Cancer; 2018 Dec; 143(12):3209-3217. PubMed ID: 29971780
[TBL] [Abstract][Full Text] [Related]
24. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma.
Pathmanathan R; Prasad U; Sadler R; Flynn K; Raab-Traub N
N Engl J Med; 1995 Sep; 333(11):693-8. PubMed ID: 7637746
[TBL] [Abstract][Full Text] [Related]
25. Second primary epithelial malignancy of nasopharynx and nasal cavity after successful curative radiation therapy of nasopharyngeal carcinoma.
Chen CL; Hsu MM
Hum Pathol; 2000 Feb; 31(2):227-32. PubMed ID: 10685638
[TBL] [Abstract][Full Text] [Related]
26. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia.
Pathmanathan R; Prasad U; Chandrika G; Sadler R; Flynn K; Raab-Traub N
Am J Pathol; 1995 Jun; 146(6):1355-67. PubMed ID: 7778675
[TBL] [Abstract][Full Text] [Related]
27. [Quantitative and localized detection of Epstein-Barr virus infectious status in nasopharyngeal carcinoma tissue].
Jiang WH; Zhao SP; Yin ZH; Li F; Chen ZH; Xiao JY
Ai Zheng; 2005 Jul; 24(7):796-800. PubMed ID: 16004803
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus RNA detection and glandular differentiation in nasopharyngeal carcinoma: report of 2 cases.
Jain D; Parkash V; Li M; Gill J; Crouch J; Howe G; Tallini G
Arch Pathol Lab Med; 2000 Sep; 124(9):1369-72. PubMed ID: 10975941
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-specific transcription in normal and malignant nasopharyngeal biopsies and in lymphocytes from healthy donors and infectious mononucleosis patients.
Tugwood JD; Lau WH; O SK; Tsao SY; Martin WM; Shiu W; Desgranges C; Jones PH; Arrand JR
J Gen Virol; 1987 Apr; 68 ( Pt 4)():1081-91. PubMed ID: 3033127
[TBL] [Abstract][Full Text] [Related]
30. Nasopharyngeal carcinoma in situ: two cases of an emerging diagnostic entity.
Cheung F; Pang SW; Hioe F; Cheung KN; Lee A; Yau TK
Cancer; 1998 Sep; 83(6):1069-73. PubMed ID: 9740069
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus DNA detection in the diagnosis of nasopharyngeal carcinoma.
Yap YY; Hassan S; Chan M; Choo PK; Ravichandran M
Otolaryngol Head Neck Surg; 2007 Jun; 136(6):986-91. PubMed ID: 17547993
[TBL] [Abstract][Full Text] [Related]
32. Outcome of patients with positive Epstein-Barr virus serologic status in the absence of nasopharyngeal carcinoma in Hong Kong.
Lo S; Ho WK; Wei WI
Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):770-2. PubMed ID: 15210561
[TBL] [Abstract][Full Text] [Related]
33. Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma.
Mäkitie AA; MacMillan C; Ho J; Shi W; Lee A; O'Sullivan B; Payne D; Pintilie M; Cummings B; Waldron J; Warde P; Irish J; Brown D; Gilbert R; Gullane P; Liu FF; Kamel-Reid S
Clin Cancer Res; 2003 Jun; 9(6):2177-84. PubMed ID: 12796384
[TBL] [Abstract][Full Text] [Related]
34. Roles of DNA cytometry and detection of EBERs in predicting a diagnosis of nasopharyngeal carcinoma.
Maohuai C; Chang AR; Shikyuen L
Anal Quant Cytol Histol; 2001 Jun; 23(3):207-12. PubMed ID: 11444190
[TBL] [Abstract][Full Text] [Related]
35. [Primary adenoid cystic carcinoma of the nasopharynx and its relation to Epstein-Barr virus infection].
He JH; Zong YS; Zhang M; Zhong BL; Liang YJ; Liang XM
Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):234-7. PubMed ID: 12882689
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and relevance of EBV latency in nasopharyngeal carcinoma in Israel.
Bar-Sela G; Kuten A; Minkov I; Gov-Ari E; Ben-Izhak O
J Clin Pathol; 2004 Mar; 57(3):290-3. PubMed ID: 14990602
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus is detected in undifferentiated nasopharyngeal carcinoma but not in lymphoepithelioma-like carcinoma of the urinary bladder.
Gulley ML; Amin MB; Nicholls JM; Banks PM; Ayala AG; Srigley JR; Eagan PA; Ro JY
Hum Pathol; 1995 Nov; 26(11):1207-14. PubMed ID: 7590694
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of EBER1 in nontumor nasopharyngeal biopsies and nontumor component of nasopharyngeal carcinoma.
Chen CL; Hsu MM; Hsu HC
Intervirology; 1996; 39(4):230-5. PubMed ID: 9078463
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus DNA and epithelial markers in nasopharyngeal carcinoma.
Friedrich RE; Bartel-Friedrich S; Lobeck H; Niedobitek G; Arps H
Med Microbiol Immunol; 2003 Aug; 192(3):141-4. PubMed ID: 12920589
[TBL] [Abstract][Full Text] [Related]
40. Analysis of EBV latency by EBER in situ hybridization in nasopharyngeal carcinoma Spanish patients.
Burgos JS; Vera-Sempere FJ
Anticancer Res; 2001; 21(6A):3921-4. PubMed ID: 11911270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
